100 related articles for article (PubMed ID: 21849287)
1. Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia.
Tsiakalos A; Routsias JG; Kordossis T; Moutsopoulos HM; Tzioufas AG; Sipsas NV
J Infect Dis; 2011 Sep; 204(6):902-11. PubMed ID: 21849287
[TBL] [Abstract][Full Text] [Related]
2. Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia.
Sipsas NV; Kokori SI; Ioannidis JP; Kyriaki D; Tzioufas AG; Kordossis T
J Infect Dis; 1999 Dec; 180(6):2044-7. PubMed ID: 10558967
[TBL] [Abstract][Full Text] [Related]
3. Circulating antibodies to endogenous erythropoietin and risk for HIV-1-related anemia.
Tsiakalos A; Kordossis T; Ziakas PD; Kontos AN; Kyriaki D; Sipsas NV
J Infect; 2010 Mar; 60(3):238-43. PubMed ID: 20036688
[TBL] [Abstract][Full Text] [Related]
4. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
5. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
Fiorentini S; Giagulli C; Caccuri F; Magiera AK; Caruso A
Pharmacol Ther; 2010 Dec; 128(3):433-44. PubMed ID: 20816696
[TBL] [Abstract][Full Text] [Related]
7. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
8. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
[TBL] [Abstract][Full Text] [Related]
9. Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants.
Lee VS; Tue-ngeun P; Nangola S; Kitidee K; Jitonnom J; Nimmanpipug P; Jiranusornkul S; Tayapiwatana C
Mol Immunol; 2010 Feb; 47(5):982-90. PubMed ID: 20022377
[TBL] [Abstract][Full Text] [Related]
10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
11. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.
Fiorentini S; Marsico S; Becker PD; Iaria ML; Bruno R; Guzmán CA; Caruso A
Vaccine; 2008 Aug; 26(36):4758-65. PubMed ID: 18602957
[TBL] [Abstract][Full Text] [Related]
13. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
14. Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
Caccuri F; D'Ursi P; Uggeri M; Bugatti A; Mazzuca P; Zani A; Filippini F; Salmona M; Ribatti D; Slevin M; Orro A; Lu W; Liò P; Gallo RC; Caruso A
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372148
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
[TBL] [Abstract][Full Text] [Related]
17. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
18. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
Pincus SH; Messer KG; Nara PL; Blattner WA; Colclough G; Reitz M
J Clin Invest; 1994 Jun; 93(6):2505-13. PubMed ID: 7515393
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
20. Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes.
Kampylafka EI; Routsias JG; Alexopoulos H; Dalakas MC; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2011 May; 36(3-4):221-7. PubMed ID: 21333492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
